Efficacy of<b><i>Cimicifuga racemosa</i></b>on climacteric complaints: A randomized study versus low-dose transdermal estradiol

Abstract

CR (40 mg/day) may be a valid alternative to low-dose TTSE2 in the management of climacteric complaints in those women who cannot be treated with or just refuse conventional strategies.